Progress of esophageal stricture prevention after endoscopic submucosal dissection by regenerative medicine and tissue engineering.
Regen Ther
; 17: 51-60, 2021 Jun.
Article
em En
| MEDLINE
| ID: mdl-33997185
Endoscopic submucosal dissection (ESD) has been widely accepted as an effective treatment for early esophageal cancer. However, post-ESD esophageal stricture remains a thorny issue. We herein review many strategies for preventing post-ESD esophageal stricture, as well as discuss their strengths and weaknesses. These strategies include pharmacological prophylaxis, esophageal stent and tissue engineering and regenerative medicine treatment. In this review, we summarize these studies and discuss the underlying progress and future directions of tissue engineering and regenerative medicine treatment.
5-FU, 5-Fluorouracil; ADSC, Autologous adipose-derived stem cells; ASGS, autologous skin graft surgery; ChST15, carbohydrate sulfotransferase 15; EBD, endoscopic balloon dilation; ECM, extracellular matrix; ESD, endoscopic submucosal dissection; Endoscopic submucosal dissection; Esophageal stricture; FCMS, fully covered metal stent; OMECs, oral mucosal epithelial cell sheets; PGAs, polyglycolic acid sheet; PIPAAm, poly(N-isopropylacrylamide); Regenerative medicine; SESCNs, superficial esophageal squamous cell neoplasms; SIS, small intestinal submucosa; SeMS, self-expandable metal stents; TA, triamcinolone acetonide; TS-PGA, triamcinolone-soaked polyglycolic acid sheet; Tissue engineering; Tß4, Thymosin ß4; ccESTD, complete circular endoscopic submucosal tunnel dissection; siRNA, small interfering RNA
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Regen Ther
Ano de publicação:
2021
Tipo de documento:
Article
País de afiliação:
China